GGrantIndex
Sort

261,768 grants matching gene therapy

Microbial exploration for new antimicrobial discovery

$1,554,067
Akintunde Emiola · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE

Advanced therapeutic for Parkinson's Disease

$1,554,020
Milton H. Werner · Inhibikase Therapeutics · R44 · FY2017 · NS

Interventions Testing Program at UM

$1,553,900
Richard A. Miller · University Of Michigan At Ann Arbor · U01 · FY2024 · AG

Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat

$1,553,843
Hugh Lee Sweeney · University Of Pennsylvania · U54 · FY2013 · AR

Clinical trials of gene therapy for Leber congenital amaurosis

$1,553,514
Samuel G Jacobson · University Of Pennsylvania · U10 · FY2008 · EY

Immunoglobulin Light Chain Fibrillogenesis

$1,553,421
Boston University Medical Campus · P01 · FY2004 · HL

Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth

$1,553,418
Roger D. Kamm · Massachusetts Institute Of Technology · U54 · FY2023 · CA

Physiology, Psychology, and Genetics of Obesity

$1,553,253
Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

Translation of Predictive Cancer Biomarkers into Clinical Practice

$1,553,201
Timothy J. Triche · Children'S Hospital Of Los Angeles · RC2 · FY2009 · CA

Biochemical Analysis of Multidrug Resistance-linked Transport Proteins

$1,553,172
Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Genomic and epigenomic mechanisms of pediatric ocular disorders

$1,553,112
Robert Hufnagel · National Eye Institute · ZIA · FY2020 · EY

Safety and PK Study in Hepatic Impairment Patients

$1,553,079
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2010 · AA

Investigating Correlates and Therapeutics of Fatigue in Cancer Patients

$1,552,962
Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2018 · NR

Epigenomic, transcriptional and cellular dissection of Alzheimer's variants

$1,552,886
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2021 · AG

IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine

$1,552,630
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

Mitigation of the Catecholamine Surge in Severely Burned Patients

$1,552,622
David N Herndon · University Of Texas Med Br Galveston · P50 · FY2014 · GM

Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy

$1,552,534
Fadlo Raja Khuri · Emory University · P01 · FY2010 · CA

Novel Therapeutics for FSHD

$1,552,437
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2019 · HD

RAGE and Mechanisms of Vascular Dysfunction

$1,552,037
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2016 · HL

Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance

$1,552,021
Ann M Chahroudi · Emory University · P01 · FY2025 · HD

SCOR IN SUDDEN CARDIAC DEATH

$1,551,922
University Of Utah · P50 · FY2004 · HL

GENES, ANEUPLOIDY AND MAMMALIAN DEVELOPMENT

$1,551,834
Johns Hopkins University · P01 · FY2001 · HD

Cellular Interactions with Thrombospondin

$1,551,374
David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Mechanisms Regulating Chronic Immune Activation in the CNS

$1,551,284
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Cell Production Facility Core

$1,551,155
Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA